Call : +918068096488
Home » Products » Anti Cancer Medicine » Peg L Asparaginase injection

Peg L Asparaginase injection

Peg L Asparaginase injection
Send Inquiry
Product Code : 03
Brand Name : Peg L-Asparkay
Product Specifications
  • Gender/Age Group
  • Suitable For All Ages, Women, Adult
  • Volume
  • 3750 IU/5ml Milliliter (mL)
  • Storage Instructions
  • Store in Cool
Product Description

Warnings:

  • Contraindications
  • Hypersensitivity
  • History of (with prior L-asparaginase treatment): pancreatitis; hemorrhagic events; serious thrombosis


Cautions:

  • No more than 2ml should be administered at any one injection site
  • Anaphylaxis or serious allergic reactions may occur, monitor patient for 1 hr after administration; discontinue with serious allergic reactions
  • Glucose intolerance reported (irreversible in some cases); monitor serum glucose
  • Hepatotoxicity and abnormal liver function, including elevations of AST (SGOT), ALT (SGPT), alkaline phosphatase, bilirubin (direct and indirect), and depression of serum albumin, and plasma fibrinogen may occur; monitor
  • Discontinue if pancreatitis occurs; evaluate patients with abdominal pain for pancreatitis
  • Serious thrombotic events, including sagittal sinus thrombosis reported; discontinue if this occurs
  • Increased prothrombin time, increased PTT and hypofibrinogenemia may occur; monitor for coagulopathy


Pregnancy & Lactation

  • Pregnancy Category: C
  • Lactation: not known if excreted in breast milk

Pregnancy Categories

  • A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
  • B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
  • C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
  • D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
  • X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.


Pharmacology

  • Mechanism of Action
  • Modified version of L-asparaginase depletes asparagine, the aminoacid required for protein synthesis, and in turn kills leukemic cells

Pharmacokinetics

  • Half-Life: 5-5.6 days
  • Onset: Asparagine depleted within 4 days (IM)
  • Duration: 21 days (IM); 2-4 weeks (IV in asparaginase naive adults)
  • Vd: 1.5 L/m² (IM in children); 2.4 L/m² (IV in adults)
  • Metabolism: Systemically
  • Peak plasma time: 3-4 days (IM)
  • Excretion: Urine (trace amounts)

Storage

  • Refrigerate
  • Do not use if cloudy or if precipitate is present
  • Do not freeze


Specifications

Brand Name Peg L-Asparkay
Best Before 24 months from Manufacture date
Form Of Medicine Injection
Grade Medicine Grade
Storage Store in cool and dry place
Packaging Size 5 ml
Trade Information
  • Payment Terms
  • Telegraphic Transfer (T/T)
  • Delivery Time
  • 30 Days
  • Sample Policy
  • Sample costs shipping and taxes has to be paid by the buyer
  • Certifications
  • USFDA

G J Pharmaceuticals LLP
X


"We deal in Foreign Markets only"
Back to top
G J PHARMACEUTICALS LLP All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.